Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Wednesday:

Merck & Co., up $6.23 to $131.75.

The drug developer received U.S. approval for a high blood pressure treatment.

Shockwave Medical Inc., up $6.54 to $322.61.

Johnson & Johnson is reportedly considering buying the medical device maker.

Cintas Corp., up $52.24 to $685.64.

The uniform rental company raised its earnings forecast for the year.

GameStop Corp., down $2.33 to $13.17.

The video game retailer’s fourth-quarter earnings and revenue fell short of Wall Street forecasts.

MiMedx Group Inc., down 1 cent to $7.61.

The developer of biomaterials for wound care challenged a negative regulatory decision from the Food and Drug Administration.

NCino Inc., up $5.72 to $35.90.

The cloud-based software company beat analysts’ fourth-quarter earnings forecasts.

Roivant Sciences Ltd., up 76 cents to $10.84.

The biopharmaceutical company is joining the S&P MidCap 400.

NovoCure Ltd., up $1.57 to $14.64.

The cancer treatment developer said a potential lung cancer therapy met a key research goal.

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up